February 14-15, 2023 in Taizhou, Jiangsu "The Fourth National Medical Powder Preparation and Characterization Technology Summit Forum"

At present, the pharmaceutical development faces good opportunities such as high international recognition, continuous dividends of development policies, broad prospects for industrial development, and smoother exchanges and cooperation. In the face of new situation and new situation, building new advantages in industrial technology is the foundation of enterprises to bring forth the old and establish a long-term foothold. In order to meet the needs of enterprises and new and old customers, the fourth National medical powder preparation and characterization technology Summit Forum held by China Powder Network will be held in Taizhou, Jiangsu Province on February 14-15, 2023. The conference focused on traditional Chinese medicine production technology, API innovation technology, high-end preparation production technology, inhaled preparation product technology, etc., paying attention to laws, regulations, policies and market trends, and promoting the inheritance and innovation development of the pharmaceutical industry.

Focus 1: pharmaceutical powder/particle preparation technology

The preparation of pharmaceutical powder/particle is to pulverize the raw material to sufficient fineness to improve the dissolution of the drug, which is conducive to the extraction of the effective ingredient or to increase the dispersion of the drug, which is conducive to the uniform mixing. So the technology of medicinal powder plays an important role in the field of medicine. The construction of the theory of ultrafine powder and micro-nano technology provides new theoretical support for the preparation, post-treatment and application technology of drug powder, and the newly developed particle design and composite technology of drug powder will boost the development of the pharmaceutical industry.

Focus two: the influence of medicinal powder on inhaled preparations

At present, with the expansion of the inhaled drug market, the deepening of people's understanding of the respiratory tract and related physiological structure, the continuous update and development of different dosage forms, and the continuous definition of drug mechanism, the inhaled drug delivery system has made great progress, and many new inhaled drugs are also under active research. Facing the domestic inhaled preparation market with huge development space, many domestic pharmaceutical enterprises (Bo Rui Pharmaceutical, healthy Yuan, Zhengda Tianqing, Hengrui Pharmaceutical and Changfeng Pharmaceutical) are competing to layout. We believe that in the near future, there will be more long-acting inhalation agents successfully marketed to benefit the world